ALAR vs. SLNO

Last updated Apr 1, 2026

Compare and contrast key facts about Alarum Technologies Ltd. (ALAR) and Soleno Therapeutics, Inc. (SLNO).

Performance

ALAR vs. SLNO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Alarum Technologies Ltd. (ALAR) and Soleno Therapeutics, Inc. (SLNO). The values are adjusted to include any dividend payments, if applicable.

ALAR vs. SLNO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
ALAR Alarum Technologies Ltd.	-30.54%	-19.13%	36.73%	223.33%	-66.20%	-50.00%	-53.14%	-94.90%	-80.59%
SLNO Soleno Therapeutics, Inc.	-27.69%	3.00%	11.68%	1,932.83%	-67.80%	-78.76%	-34.35%	71.93%	-35.62%

Fundamentals

Market Cap ALAR : $52.71M SLNO : $1.82B
EPS ALAR : $0.12 SLNO : $0.39
PE Ratio ALAR : 50.25 SLNO : 85.34
PS Ratio ALAR : 1.19 SLNO : 9.36
PB Ratio ALAR : 1.64 SLNO : 4.04
Total Revenue (TTM) ALAR : $40.79M SLNO : $190.41M
Gross Profit (TTM) ALAR : $23.85M SLNO : $96.84M
EBITDA (TTM) ALAR : $1.04M SLNO : $9.41M

Returns By Period

In the year-to-date period, ALAR achieves a -30.54% return, which is significantly lower than SLNO's -27.69% return.

ALAR

• 1D: 6.43%
• 1M: -8.46%
• YTD: -30.54%
• 6M: -60.21%
• 1Y: -4.64%
• 3Y*: 50.17%
• 5Y*: -15.82%
• 10Y*: —

SLNO

• 1D: 9.99%
• 1M: -14.31%
• YTD: -27.69%
• 6M: -50.47%
• 1Y: -53.14%
• 3Y*: 150.11%
• 5Y*: 11.25%
• 10Y*: -9.78%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ALAR vs. SLNO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ALAR

ALAR Risk / Return Rank: 41
ALAR Sharpe Ratio Rank: 39
ALAR Sortino Ratio Rank: 44
ALAR Omega Ratio Rank: 43
ALAR Calmar Ratio Rank: 39
ALAR Martin Ratio Rank: 40

SLNO

SLNO Risk / Return Rank: 10
SLNO Sharpe Ratio Rank: 8
SLNO Sortino Ratio Rank: 10
SLNO Omega Ratio Rank: 10
SLNO Calmar Ratio Rank: 12
SLNO Martin Ratio Rank: 10

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ALAR vs. SLNO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Alarum Technologies Ltd. (ALAR) and Soleno Therapeutics, Inc. (SLNO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ALAR	SLNO	Difference
Sharpe ratio Return per unit of total volatility	-0.06	-0.83	+0.78
Sortino ratio Return per unit of downside risk	0.57	-1.09	+1.66
Omega ratio Gain probability vs. loss probability	1.07	0.86	+0.21
Calmar ratio Return relative to maximum drawdown	-0.09	-0.81	+0.72
Martin ratio Return relative to average drawdown	-0.19	-1.51	+1.32
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ALAR vs. SLNO - Sharpe Ratio Comparison

The current ALAR Sharpe Ratio is -0.06, which is higher than the SLNO Sharpe Ratio of -0.83. The chart below compares the historical Sharpe Ratios of ALAR and SLNO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ALAR	SLNO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.06	-0.83	+0.78
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.17	0.05	-0.21
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.05	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.53	-0.09	-0.44

Correlation

The correlation between ALAR and SLNO is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ALAR vs. SLNO - Dividend Comparison

Neither ALAR nor SLNO has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

ALAR vs. SLNO - Drawdown Comparison

The maximum ALAR drawdown since its inception was -99.95%, roughly equal to the maximum SLNO drawdown of -99.86%. Use the drawdown chart below to compare losses from any high point for ALAR and SLNO.

Drawdown Indicators

	ALAR	SLNO	Difference
Max Drawdown Largest peak-to-trough decline	-99.95%	-99.86%	-0.09%
Max Drawdown (1Y) Largest decline over 1 year	-67.10%	-66.04%	-1.06%
Max Drawdown (5Y) Largest decline over 5 years	-90.73%	-95.49%	+4.76%
Max Drawdown (10Y) Largest decline over 10 years	—	-99.13%	—
Current Drawdown Current decline from peak	-99.81%	-94.90%	-4.91%
Average Drawdown Average peak-to-trough decline	-95.53%	-90.57%	-4.96%
Ulcer Index Depth and duration of drawdowns from previous peaks	33.66%	35.50%	-1.84%

Volatility

ALAR vs. SLNO - Volatility Comparison

Alarum Technologies Ltd. (ALAR) has a higher volatility of 25.58% compared to Soleno Therapeutics, Inc. (SLNO) at 17.95%. This indicates that ALAR's price experiences larger fluctuations and is considered to be riskier than SLNO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ALAR	SLNO	Difference
Volatility (1M) Calculated over the trailing 1-month period	25.58%	17.95%	+7.63%
Volatility (6M) Calculated over the trailing 6-month period	50.15%	50.62%	-0.47%
Volatility (1Y) Calculated over the trailing 1-year period	84.13%	64.08%	+20.05%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	96.34%	243.38%	-147.04%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	104.99%	185.10%	-80.11%

Financials